Execute the drug program pipeline for esophageal cancer research, including drug screening, efficacy analysis, and therapeutic candidate evaluation.

This session aimed to execute an end-to-end drug program pipeline for esophageal cancer (esophageal adenocarcinoma, EAC) research, covering drug/target screening, efficacy analysis, and therapeutic candidate evaluation.

The session produced a program dossier and supporting scientific, regulatory, commercial, and patient-priorities briefs alongside target nomination, design, and competitive-landscape data and figures (e.g., driver landscape and whitespace mapping), plus protein complex structure files for candidate targets. Separately, the session packaged a "Manuscript Architect" specialist agent (identity, system prompt, recreation script, README, and MIT license) and published it as a public GitHub repository so it can be recreated in other Claude Science workspaces. The agent's creator confirmed the published bundle contained no secrets before pushing. The session closed by offering to next run this specialist on the EAC program to draft a preprint and carry it through two rounds of peer review.

Key research artifacts include program_dossier.json, scientific_development_plan.md, FINAL_program_deliverable.md, target_nomination.csv/target_nomination.png, design_leads.csv/design_results.png, competitive_landscape.csv/eac_whitespace_map.png/eac_driver_landscape.png, the regulatory_brief.md, commercial_financing_brief.md, and patient_priorities_brief.md, plus two structural files (gucy2c_bb2_complex.pdb, dkk1_bb1_complex.pdb). Separately, the Manuscript Architect agent bundle (profile.json, system_promp